Cardiology
Advertisement
A study compared health-related QOL and symptom burden in patients with prefibrotic MF and those with overt MF.
Dr. Marc Bonaca discusses the VOYAGER PAD study, which showed the efficacy of rivaroxaban in lower extremity PAD.
Ticagrelor monotherapy after dual-antiplatelet therapy following PCI with DES yields superior outcomes.
Dr. Eugenia Alleva discusses a study that found women with dysmenorrhea have increased cardiovascular risk.
The use of ADHD medications may be linked to an increased risk of cardiovascular disease.
Dr. Clark details the MINT trial, which addressed the accurate transfusion threshold in patients with acute MI and anemia.
Dr. Okumus details the ORBITA-2 trial, which marked a significant advancement in understanding and treating stable angina.
Dr. Benjamin Horne discusses a study that showed increases in PM2.5 during the summer and winter impact heart health.
Having multiple risk factors for cardiovascular disease may increase the risk of rheumatoid arthritis treatment failure.
Dr. Lichaa continues to summarized some technical tips for meeting challenges in navigating the cardiovascular system.
Dr. Ijeoma Eleazu talks about the harmful impact of cumulative stress on cardiovascular health.
CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial.
CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023.
Dr. Christian Ruff on positive results from the AZALEA-TIMI 71 study of patients with AF at moderate to high risk of stroke.
James K. Min, MD, founder and CEO of Cleerly, talks about improved screening for heart disease using a digital care platform.
Dr. Babak Nazer discusses an experimental, leadless pacemaker that shows great potential in improving patient QoL.
Dr. Lichaa details his presentation from TCT 2023, which covers tips and tricks for dealing with peripheral challenges.
Drs. Jim List and Puneet Mohan discuss the Librexia program and the benefits of milvexian treatment.
Dr. Karthik Gonuguntla discusses the study he led on cardiovascular health disparities in American Indian adults.
Stenting improves chest pain, exercise capacity, and quality of life among patients with stable chest pain.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.